Anionic polypeptide carboxylated biological nano magnetic bead and preparation method thereof
An anionic polypeptide and bio-nano technology, applied in the field of nano-magnetic bead application and medical detection, can solve the problem that the performance of modified biological nano-magnetic beads varies greatly, the bacterial survival rate is low, the yield of nano-magnetic beads is low, and the success rate of DNA transformation and expression is low. and other problems, to achieve the effect of good anti-environmental impact ability, high practicability, and large amount of binding antibodies
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0059] An anionic polypeptide carboxylated biological nano-magnetic bead, which is formed by fusion expression of an anionic polypeptide polymer grafted with polyethylene glycol and connected to the membrane protein of the biological nano-magnetic bead through a flexible linker. The amino acid residue of the flexible linker is GCVA (DLGGV) 2 GVC(GA) 3 MADEGAG; the amino acid residue of the anionic polypeptide polymer is
Embodiment 2
[0061] An anionic polypeptide carboxylated biological nano-magnetic bead, which is formed by fusion expression of an anionic polypeptide polymer grafted with polyethylene glycol and connected to the membrane protein of the biological nano-magnetic bead through a flexible linker. The amino acid residue of the flexible linker is GCVA (DLGGV) 2 GVC(GA) 3 MADEGAG; the amino acid residue of the anionic polypeptide polymer is
Embodiment 3
[0063] An anionic polypeptide carboxylated biological nano-magnetic bead, which is formed by fusion expression of an anionic polypeptide polymer grafted with polyethylene glycol and connected to the membrane protein of the biological nano-magnetic bead through a flexible linker. The amino acid residue of the flexible linker is GCVA (DLGGV) 2 GVC(GA) 3 MADEGAG; the amino acid residue of the anionic polypeptide polymer is
[0064] Preparation:
[0065] A. Construct a mutant strain of bacterial magnetic particle membrane protein gene mamC or mamF deletion, and obtain a first-class recombinant strain;
[0066] B. Anionic polypeptides are prepared by DNA synthesis, and the anionic polypeptides are fused with the bacterial magnetic particle membrane protein gene mamC or mamF through a flexible linker to form a gene fusion expression vector;
[0067] C. Import the expression vector obtained in step B into the primary recombinant strain obtained in step A, and screen out the se...
PUM
Property | Measurement | Unit |
---|---|---|
particle diameter | aaaaa | aaaaa |
concentration | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com